Sophiko Erbel-Khurtsidze
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Sophiko Erbel-Khurtsidze has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Artur Lichtenberg
Klinik für Herzchirurgie, Universitätsklinikum Düsseldorf, Heinrich-Heine-Universität, Düsseldorf, Deutschland
1 shared publication- Artur Lichtenberg
Department of Cardiac Surgery and Research Group for Experimental Surgery, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Hospital, Düsseldorf, Germany
1 shared publication Detlef Moka
Zentrum für Nuklearmedizin, Essen, Deutschland
1 shared publication- Hug Aubin
Department of Cardiac Surgery, Medical Faculty and University Hospital Düsseldorf, Heinrich-Heine-University Düsseldorf, 40225 Düsseldorf, Germany
1 shared publication - Igor Tudorache
Department of Cardiac Surgery, Medical Faculty, Heinrich-Heine University, 40225 Düsseldorf, Germany
1 shared publication Katja Brandt-mAinz
Zentrum für Nuklearmedizin, Essen, Deutschland
1 shared publication
Latest Publications
- Open Access
- 10 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (4) , 929
Heart Transplantation of the Elderly—Old Donors for Old Recipients: Can We Still Achieve Acceptable Results?
As society is ageing, an increasing prevalence of elderly heart failure patients will be expected. In order to increase the donor pool, acceptance of older donors might be a reasonable choice. All patients undergoing heart transplantation between 2010 and 2021 at a single department were retrospectively reviewed and divided into different study groups with regard to recipient (≤60 years (RY) or >60 years (RO)) and donor age (≤50 years (DY) or >50 years (DO). A total of n = 201 patients were included (DY/RY, n = 91; DO/RY, n = 38; DY/RO, n = 41; DO/RO, n = 31). Neither incidence of severe primary graft dysfunction (p = 0.64) nor adverse events, such as kidney failure (p = 0.27), neurological complications (p = 0.63), infections (p = 0.21) or acute graft rejection (p = 1.00), differed between the groups. However, one-year survival was impaired in the DO/RO group (56.0%) compared to the other groups (DY/RY: 86.1%, DY/RO: 78.8%, DO/RY: 74.2%, p = 0.02). Given the impaired one-year survival, acceptance of grafts from old donors for old recipients should be performed with caution and by experienced centres only. Nevertheless, because of the otherwise dismal prognosis of elderly heart failure patients, transplantation of patients may still improve the therapy outcome.
- 10 February 2022
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 11 (4) , 929
Open AccessHeart Transplantation of the Elderly—Old Donors for Old Recipients: Can We Still Achieve Acceptable Results?
As society is ageing, an increasing prevalence of elderly heart failure patients will be expected. In order to increase the donor pool, acceptance of older donors might be a reasonable choice. All patients undergoing heart transplantation between 2010 and 2021 at a single department were retrospectively reviewed and divided into different study groups with regard to recipient (≤60 years (RY) or >60 years (RO)) and donor age (≤50 years (DY) or >50 years (DO). A total of n = 201 patients were included (DY/RY, n = 91; DO/RY, n = 38; DY/RO, n = 41; DO/RO, n = 31). Neither incidence of severe primary graft dysfunction (p = 0.64) nor adverse events, such as kidney failure (p = 0.27), neurological complications (p = 0.63), infections (p = 0.21) or acute graft rejection (p = 1.00), differed between the groups. However, one-year survival was impaired in the DO/RO group (56.0%) compared to the other groups (DY/RY: 86.1%, DY/RO: 78.8%, DO/RY: 74.2%, p = 0.02). Given the impaired one-year survival, acceptance of grafts from old donors for old recipients should be performed with caution and by experienced centres only. Nevertheless, because of the otherwise dismal prognosis of elderly heart failure patients, transplantation of patients may still improve the therapy outcome.
- 6 September 2021
- Published by Springer Nature in Herz
- Vol. 46 (5) , 485-496
Kardiale Amyloidose und Aortenklappenstenose
Zusammenfassung Die Aortenklappenstenose im höheren Alter ist in den Blickpunkt der Kardiologie und Herzchirurgie gerückt, nachdem transvaskuläre und transluminale minimal-invasive Verfahren zur Klappenimplantation entwickelt worden waren. Die Beobachtung von Amyloidablagerungen in operativ entfernten Klappen führte zur Diagnostik der Amyloidose des Myokards, die bei bis zu 20 % der Patienten, die zur Klappenimplantation kommen, aufgedeckt wurde. Klinische Zeichen wie Karpaltunnelsyndrom oder Bizepssehnenruptur sind zu beachten. Eine wichtige diagnostische Rolle spielt neben EKG, Echokardiogramm und Magnetresonanztomographie die 99mTechnetium-Knochenszintigraphie. Das Zusammentreffen von Aortenklappenstenose und Amyloidose erklärt die besondere hämodynamische Situation eines niedrigen Gradienten, mit niedrigem Blutfluss bei hochgradiger Klappeneinengung. Die interventionelle oder chirurgische Klappenimplantation verbessert die Prognose dieser Patienten ähnlich wie bei reiner Aortenklappenstenose, gefolgt von einer spezifischen medikamentösen Therapie in Abhängigkeit vom Amyloidosetyp.
- 6 September 2021
- Published by Springer Nature in Herz
- Vol. 46 (5) , 485-496
Kardiale Amyloidose und Aortenklappenstenose
Zusammenfassung Die Aortenklappenstenose im höheren Alter ist in den Blickpunkt der Kardiologie und Herzchirurgie gerückt, nachdem transvaskuläre und transluminale minimal-invasive Verfahren zur Klappenimplantation entwickelt worden waren. Die Beobachtung von Amyloidablagerungen in operativ entfernten Klappen führte zur Diagnostik der Amyloidose des Myokards, die bei bis zu 20 % der Patienten, die zur Klappenimplantation kommen, aufgedeckt wurde. Klinische Zeichen wie Karpaltunnelsyndrom oder Bizepssehnenruptur sind zu beachten. Eine wichtige diagnostische Rolle spielt neben EKG, Echokardiogramm und Magnetresonanztomographie die 99mTechnetium-Knochenszintigraphie. Das Zusammentreffen von Aortenklappenstenose und Amyloidose erklärt die besondere hämodynamische Situation eines niedrigen Gradienten, mit niedrigem Blutfluss bei hochgradiger Klappeneinengung. Die interventionelle oder chirurgische Klappenimplantation verbessert die Prognose dieser Patienten ähnlich wie bei reiner Aortenklappenstenose, gefolgt von einer spezifischen medikamentösen Therapie in Abhängigkeit vom Amyloidosetyp.